An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19
Research Square (2021) - Comments
doi: 10.21203/rs.3.rs-138540/v2 

Ilad Alavi Darazam, Firouze Hatami, Mohammad Mahdi Rabiei, Mohamad Amin Pourhoseingholi, Minoosh Shabani, Shervin Shokouhi, Omid Moradi, Farid Javandoust Gharehbagh, Nasrinsadat Mirtalaee, Halimeh Negahban, Mahdi Amirdosara, Masoud Zangi, Mohammadreza Hajiesmaeili, Muhanna Kazempour, Navid Shafigh